Filing Details
- Accession Number:
- 0001209191-22-013787
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-28 19:08:02
- Reporting Period:
- 2022-02-24
- Accepted Time:
- 2022-02-28 19:08:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1468748 | Kodiak Sciences Inc. | KOD | Biological Products, (No Disgnostic Substances) (2836) | 270476525 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1754181 | Victor Perlroth | 1200 Page Mill Road Palo Alto CA 94304 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-02-24 | 1,000,000 | $9.20 | 2,508,038 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-25 | 340,000 | $8.99 | 2,168,038 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- 2,000,000 shares of common stock owned by the Reporting Person were pledged as collateral to secure obligations under a loan entered into in connection with a previously disclosed Stipulation for Settlement with the Reporting Person's spouse. The sales reported in this Form 4 were sold pursuant to a contractual enforcement action, pursuant to which the pledgee bank unilaterally liquidated the shares. The Reporting Person was not involved in the determination to sell such shares.
- The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $8.95 to $9.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
- The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $8.72 to $9.40, inclusive.
Billionaire Hedge Funds
